To replay video, click on the refresh
button at the top of your screen
New clinical
trial results presented
at annual meeting of American Diabetes Association
June 2005 (Newstream) -- Findings from a
new study offer good news for the more than 18 million Americans
with Type 2 diabetes. The results, to be presented at the American
Diabetes Association's annual meeting on June 11, show consuming Diachrome, a nutritional
therapy containing chromium picolinate and biotin, can significantly
lower both blood sugar levels and cholesterol in people with type 2
diabetes. The most dramatic improvements were seen in study
participants that had the highest blood sugar levels, despite the
use of prescription medication.
Diachrome's beneficial effects are
significant given the wide-spread concern stemming from a recent
medical report that found two-thirds of the nation's type 2
diabetics don't have their blood sugar under control -- putting them
at higher risk of the disease's dangerous complications, including
heart disease, kidney failure and blindness (American College of
Endocrinology, May 2005).
The randomized, double-blind,
placebo-controlled, multi-center study examined an ethnically
diverse group of 369 people with diabetes. Thirty percent of
participants were of Hispanic origin - a group with a higher risk
for the disease.
The study was conducted by Nutrition 21,
in collaboration with XLHealth, a nationally recognized disease
management firm handling chronically ill patients for the Centers
for Medicare and Medicaid Services (CMS).
Now,
keep up to date with daily feeds of newly posted stories about America's
Seniors...click on the box to the left